The first study that investigated PD-L1 expression (defined as cell-surface membrane staining > 5%) in breast cancer found a higher PD-L1 expression in TNBCs as compared to non-TNBCs (p < 0.001) [13]. Here, CD274 is linked to breast carcinoma.